루멘스바이오스 Capital reduction filings (감자)

Fields as filed (DART)

Values are exactly as filed. We did not round or edit them. A hyphen in the original means no value.

Board resolution date

2026년 09월 11일

Shares reduced, common (shares)

20,669,799

Shares reduced, other classes (shares)

-

Par value per share (KRW)

1,000

Capital before reduction (KRW)

25,837,248,000

Capital after reduction (KRW)

5,167,449,000

Total shares before reduction, common

25,837,248

Total shares after reduction, common

5,167,449

Reduction ratio, common (percent)

80.00

Reduction record date

2026년 11월 25일

Reduction method

기명식 보통주 5주를 동일한 액면주식 1주로 무상병합

Reason for reduction

결손금보전을 통한 재무구조 개선

Planned shareholders meeting date

2026년 11월 09일

Planned trading halt, start

2026년 11월 24일

Planned trading halt, end

2026년 12월 15일

Planned listing date of new shares

2026년 12월 16일

Fair Trade Commission filing required

미해당

Other filings by the same company

• 루멘스바이오스KOSDAQ 2026-09-23

  [기재정정]주요사항보고서(유상증자결정)

  1,785,714 new shares / 24,051,534 before / new share ratio 7.42 percent

• 루멘스바이오스KOSDAQ 2026-09-17

  [기재정정]주요사항보고서(감자결정)

• 루멘스바이오스KOSDAQ 2026-09-17

  [기재정정]주요사항보고서(유상증자결정)

• 루멘스바이오스KOSDAQ 2026-09-14

  [첨부정정]주요사항보고서(감자결정)

• 루멘스바이오스KOSDAQ 2026-09-14

  [첨부정정]주요사항보고서(유상증자결정)

• 루멘스바이오스KOSDAQ 2026-09-11

  주요사항보고서(감자결정)

• 루멘스바이오스KOSDAQ 2026-09-11

  주요사항보고서(유상증자결정)

A corrected report gets its own filing number. If numbers differ, the later filing is the newer one.